Class II
Ongoing
IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPharma Inc., 8041 Arco corporate Drive, Suite 200, Raleigh, NC 27617, USA, Manufactu…
Why: Lack of assurance of Sterility:
- Company
- ACCORD BIOPHARMA INC
Raleigh, NC, United States - Reported
- Jul 8, 2026
- Recall started
- Jun 10, 2026
- Where sold
- US Nationwide.
- Amount
- 326 vials
- Full product description
- IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPharma Inc., 8041 Arco corporate Drive, Suite 200, Raleigh, NC 27617, USA, Manufactured at: Catalent Indiana, LLC, 1300 S. Patterson Drive, Bloomington, IN 47403, USA, NDC 69448-019-26.
- Lots / codes affected
- Lot # 004L24A, Exp Date: 02/19/2027.
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.